DUBLIN, May 24, 2022--(BUSINESS WIRE)--The "Facial Injectable Market Size, Share & Trends Analysis Report by Product (Collagen, Hyaluronic Acid, Botulinum Toxin Type A, Calcium Hydroxylapatite, Polymer Fillers), by Application (Aesthetic, Therapeutic), by Region, and Segment Forecasts 2022-2030" report has been added to ResearchAndMarkets.com's offering.
The global facial injectable market size is expected to reach USD 35.0 billion by 2030 and is expected to register a CAGR of 9.1% from 2022 to 2030
The facial injectable is a substance that is used to reduce wrinkles and restore volume and fullness in the face. It is injected beneath the facial skin surface. Some commonly used facial injectable include hyaluronic acid, botulinum toxin type A, and polymer fillers.
Growing focus on physical appearance, especially in developing countries is one of the key factors expected to drive the market. In addition, a shift in consumer preference towards minimally invasive procedures is also expected to support market growth.
According to the American Society of Plastic Surgeons (ASPS), in 2020, botulinum toxin A and soft tissue fillers were among the top 5 minimally invasive procedures carried out in the U.S. Thus, facial injectable holds high growth prospects in the years to come.
In Asia Pacific, the market is expected to serve as a key revenue-generating center. The region is backed by countries such as India, where a growing focus on physical appearance is expected to create a lucrative opportunity for the market. Companies such as Allergan are also expanding their presence in the country owing to the rise in the number of middle-class populations backed by increasing disposable income.
The onset of the pandemic led to nonurgent and cosmetic surgeries being put on hold in the first and second quarters of 2020. However, the later months witnessed high demand for aesthetic consultations and procedures as patients were willing to undergo cosmetic treatments now more than ever due to high disposable income and desire to look appealing on zoom calls and online meetings.
Facial Injectable Market Report Highlights
The botulinum toxin type A segment is projected to dominate the market throughout the forecast period. It is one of the most popularly used minimally invasive procedures.
The aesthetic segment is projected to grow fast over the forecast period owing to the rise in the use of facial injectables for aesthetic procedures such as the treatment of wrinkles on the face.
North America dominated the market with a revenue share of 41.0% IN 2021 owing to the easy availability of the products and the presence of a large number of skilled surgeons.
Key Topics Covered:
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
Chapter 3. Facial Injectable Market Variables, Trends & Scope
3.1. Market Lineage outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.4. Facial injectable: Market Analysis Tools
3.4.1. Industry Analysis-Porter's
3.4.2. PESTEL Analysis
3.4.3. Major Deals & Strategic Alliances Analysis
Chapter 4. Facial Injectable Market: Segment Analysis, by Product, 2018-2030 (USD Million)
4.1. Segment Dashboard
4.2. Product Market Share Analysis, 2022 & 2030
4.3. Global Facial Injectable Market, by product, 2018 to 2030
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.6. Hyaluronic Acid (HA)
4.7. Botulinum Toxin Type A
4.8. Calcium Hydroxylapatite (CaHA)
4.9. Polymer Fillers
126.96.36.199. Polymethylmethacrylate beads (PMMA Microspheres)
188.8.131.52. Poly-L-Lactic Acid (PLLA)
Chapter 5. Facial Injectable Market: Segment Analysis, by Application, 2018-2030 (USD Million)
5.1. Segment Dashboard
5.2. Category Market Share Analysis, 2022 & 2030
5.3. Global Facial injectable Market, by Application, 2018 to 2030
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
Chapter 6. Facial Injectable Market: Regional Market Analysis, by Region, 2018-2030 (USD Million)
6.1. Regional Market Dashboard
6.2. Regional Market Share Analysis, 2022 & 2030
6.3. Market Size, & Forecasts, and Trend Analysis, 2018 to 2030
Chapter 7. Facial Injectable Market-Competitive Analysis
Merz Pharma GmbH & Co. Kgaa
Suneva Medical, Inc.
Anika Therapeutics, Inc.
Prollenium Medical Technologies Inc.
For more information about this report visit https://www.researchandmarkets.com/r/sbkk8y
View source version on businesswire.com: https://www.businesswire.com/news/home/20220524005769/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900